DexCom Reports Strong Q2 Earnings and Revenue, Beats Estimates
DexCom (NASDAQ:DXCM) reported second-quarter Non-GAAP earnings per share of $0.70, exceeding estimates by $0.09. The company also generated revenue of $1.31 billion in the quarter, a year-over-year increase of 12.9%, and beat expectations by $20 million. In addition to strong quarterly performance, DexCom raised its fiscal year 2026 guidance, increasing the midpoint of its annual revenue forecast. The company's results reflect continued demand for its diabetes monitoring products and a robust market position in the healthcare technology sector.
Tickers: $DXCM
Topics: Earnings Guidance Update